Loading...
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
Sectors
Issues Raised
Project Information
Investment ID: 4083-SRI
Bank: Asian Development Bank
Environmental Category: B
Country: Sri Lanka
Region: South Asia
Approval Date: July 8, 2021
Investment Types: Loans
Total Project Cost: USD 95.9 million
Total Complaints: 2
Description
The project will provide the Government of Sri Lanka with immediate and flexible financing to support the national COVID-19 vaccination program through APVAX and the regular country allocation. The APVAX allocation comprises a rapid response component (RRC) to support the purchase of Asian Development Bank (ADB) eligible COVID-19 vaccines, while the project investment component (PIC) financed by the regular country allocation will support strengthening of the vaccination information dissemination and monitoring systems, vaccine transportation capacity, and vaccine-related medical waste management.
Investments
| Investment Type | ID | Amount | Status | Bank | Client |
|---|---|---|---|---|---|
| Loans | 4083-SRI | USD 84.0 million | Planned | ADB |
Related Complaints
| Asian Development Bank SPF CRP Complaints | IAM | Country | Date Filed | Status |
|---|---|---|---|---|
| Responsive COVID-19 Vaccination for Recovery Project under the Asia Pacific Vaccine Access Facility | ADB SPF CRP | Maldives | 28/08/2023 | Closed Without Outputs |
| Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility | ADB SPF CRP | Sri Lanka | 30/06/2021 | Closed Without Outputs |